Goeltz II Robert C. - Insider Non-Derivative Transactions at Arcus Biosciences, Inc. (RCUS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 23, 2024, Goeltz II Robert C.'s relationship to Arcus Biosciences, Inc. (RCUS) is Officer (Chief Financial Officer), and currently has 73,831 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RCUS insiders.
Data Source: SEC.
Goeltz II Robert C. - Insider Non-Derivative Transactions of RCUS Common Stock
Goeltz II Robert C. - Insider Non-Derivative Transactions at RCUS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 24, 2024 | Acquisition -- (Common Stock) | 21300 | 0 | 73131 |
| Jan 24, 2024 | Acquisition -- (Common Stock) | 22000 | 0 | 73831 |
| Jan 3, 2024 | Sell -- (Common Stock) | 2004 | 20 | 51831 |
| Dec 20, 2023 | Disposition -- (Common Stock) | 2808 | 18.09 | 53835 |
| Dec 19, 2023 | Disposition -- (Common Stock) | 2749 | 17.74 | 56643 |
| Jun 8, 2023 | Sell -- (Common Stock) | 4049 | 20.04 | 59392 |
| Jan 24, 2023 | Acquisition -- (Common Stock) | 34000 | 0 | 63441 |